STEPHENS INC /AR/ - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$234,166
+10.5%
6,130
+4.3%
0.00%0.0%
Q2 2023$211,911
+89.9%
5,875
+101.1%
0.00%
+100.0%
Q1 2023$111,591
-32.3%
2,922
+0.8%
0.00%
-33.3%
Q4 2022$164,953
+43.4%
2,8990.0%0.00%
+50.0%
Q3 2022$115,000
-10.2%
2,8990.0%0.00%
-33.3%
Q2 2022$128,000
+10.3%
2,8990.0%0.00%
+50.0%
Q1 2022$116,000
+13.7%
2,899
+14.6%
0.00%0.0%
Q4 2021$102,000
-1.0%
2,5300.0%0.00%0.0%
Q3 2021$103,000
-10.4%
2,5300.0%0.00%0.0%
Q2 2021$115,000
+9.5%
2,5300.0%0.00%0.0%
Q1 2021$105,000
+356.5%
2,530
+377.4%
0.00%
Q4 2020$23,000
-72.0%
530
-83.1%
0.00%
-100.0%
Q3 2020$82,000
-23.4%
3,133
-21.7%
0.00%0.0%
Q2 2020$107,000
-25.2%
4,000
-63.6%
0.00%
-60.0%
Q1 2017$143,000
+31.2%
11,0000.0%0.01%
+25.0%
Q4 2016$109,000
-18.0%
11,0000.0%0.00%
-33.3%
Q3 2016$133,000
+40.0%
11,0000.0%0.01%
+50.0%
Q2 2016$95,000
-8.7%
11,0000.0%0.00%
-20.0%
Q1 2016$104,000
-45.5%
11,0000.0%0.01%
-50.0%
Q4 2015$191,000
+29.1%
11,0000.0%0.01%
+25.0%
Q3 2015$148,000
-40.3%
11,0000.0%0.01%
-27.3%
Q2 2015$248,000
+58.0%
11,0000.0%0.01%
+57.1%
Q1 2015$157,000
+25.6%
11,000
-15.4%
0.01%
+16.7%
Q4 2014$125,000
+5.9%
13,0000.0%0.01%0.0%
Q3 2014$118,00013,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders